As of 2025-07-09, the EV/EBITDA ratio of Vcanbio Cell & Gene Engineering Corp Ltd (600645.SS) is 79.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 600645.SS's latest enterprise value is 11,107.43 mil CNY. 600645.SS's TTM EBITDA according to its financial statements is 139.95 mil CNY. Dividing these 2 quantities gives us the above 600645.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 25.9x - 29.4x | 28.0x |
| Forward P/E multiples | 10.4x - 19.3x | 14.7x |
| Fair Price | 10.00 - 16.01 | 12.15 |
| Upside | -62.6% - -40.1% | -54.6% |
| Date | EV/EBITDA |
| 2025-07-07 | 76.02 |
| 2025-07-04 | 76.42 |
| 2025-07-03 | 68.57 |
| 2025-07-02 | 66.73 |
| 2025-07-01 | 68.23 |
| 2025-06-30 | 67.50 |
| 2025-06-27 | 66.99 |
| 2025-06-26 | 66.33 |
| 2025-06-25 | 67.29 |
| 2025-06-24 | 67.29 |
| 2025-06-23 | 65.82 |
| 2025-06-20 | 65.49 |
| 2025-06-19 | 65.86 |
| 2025-06-18 | 67.33 |
| 2025-06-17 | 68.70 |
| 2025-06-16 | 70.00 |
| 2025-06-13 | 69.13 |
| 2025-06-12 | 73.75 |
| 2025-06-11 | 73.38 |
| 2025-06-10 | 74.38 |
| 2025-06-09 | 68.97 |
| 2025-06-06 | 68.13 |
| 2025-06-05 | 69.13 |
| 2025-06-04 | 70.44 |
| 2025-06-03 | 69.74 |
| 2025-05-30 | 65.22 |
| 2025-05-29 | 64.62 |
| 2025-05-28 | 61.61 |
| 2025-05-27 | 63.22 |
| 2025-05-26 | 63.08 |
| 2025-05-23 | 64.12 |
| 2025-05-22 | 63.75 |
| 2025-05-21 | 64.92 |
| 2025-05-20 | 66.39 |
| 2025-05-19 | 65.26 |
| 2025-05-16 | 65.79 |
| 2025-05-15 | 64.42 |
| 2025-05-14 | 64.29 |
| 2025-05-13 | 64.15 |
| 2025-05-12 | 64.25 |
| 2025-05-09 | 63.45 |
| 2025-05-08 | 63.38 |
| 2025-05-07 | 62.65 |
| 2025-05-06 | 62.15 |
| 2025-04-30 | 60.07 |
| 2025-04-29 | 62.58 |
| 2025-04-28 | 62.81 |
| 2025-04-25 | 61.94 |
| 2025-04-24 | 64.75 |
| 2025-04-23 | 64.99 |